中文名称: 兔抗BCL9多克隆抗体
| Background: | BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies. | 
| Applications: | ELISA, IHC | 
| Name of antibody: | BCL9 | 
| Immunogen: | Fusion protein of human BCL9 | 
| Full name: | B-cell CLL/lymphoma 9 | 
| Synonyms: | LGS | 
| SwissProt: | O00512 | 
| ELISA Recommended dilution: | 5000-10000 | 
| IHC positive control: | Human thyroid cancer and human cervical cancer | 
| IHC Recommend dilution: | 25-100 | 
	
 
	
 
	
 
 购物车
购物车 帮助
帮助
 021-54845833/15800441009
021-54845833/15800441009 
              